深圳商报·读创客户端记者 郑恺 近日，中国风险投资研究院权威发布"2025中国风险投资行业年度榜单·金投奖榜单·年中榜"。深圳市南山战略新兴产业投资有限公司（简称：南山战新投） 实力入选"2025年度中国影响力国资投资机构TOP50"，行业影响力获权威认可。 | 序号 | 简称 | 序号 | 简称 | | --- | --- | --- | --- | | 01 | 保利资本 | 26 | 两江资本 | | 02 | 北汽产投 | 27 | 临港科创投 | | 03 | 策源资本 | 28 | 南山战新投 | | 04 | 长江创投 | 29 | 南通投管 | | 05 | 重庆渝富基金 | 30 | 瑞力投资 | | 06 | 福创投 | 31 | 山东新动能资本 | | --- | --- | --- | --- | | 07 | 富浙基金 | 32 | 上海国投孚腾资 | | 08 | 工控资本 | 33 | 深高新投 | | 09 | 广东恒健控股 | 34 | 深投控资本 | | 10 | 广汽资本 | 35 | 四川省科创投资 | | 11 | 广投资本 | 36 | 苏创投 | | 12 | 广 ...

本报北京9月17日电 （记者李心萍）记者从国新办新闻发布会获悉："十四五"以来，中央企业累计上交 税费超10万亿元，向社保基金划转国有股权1.2万亿元，高标准履行社会责任。 (责编：牛镛、袁勃) 关注公众号：人民网财经 "十四五"以来，中央企业科技创新取得了积极进展和重要成效，研发经费年均增长6.5%，已连续3年每 年投入超1万亿元。2024年，中央企业研发经费达1.1万亿元，其中基础研究投入占比达8.8%。 新动能新优势加快塑造，"十四五"以来，中央企业在战略性新兴产业领域累计投资达8.6万亿元，较"十 三五"时期有了大幅提升。（相关报道见第二版） 《 人民日报 》（ 2025年09月18日 01 版） ...

日前，温州市科技创新创业投资基金2025年度第二批拟参股子基金申报指南的公告公布：为引导社会资本加大对温州市战略性新兴产业、高新技术 产业等产业领域的投资，助推种子期、初创期、成长期科技企业快速成长，根据《温州市科技创新创业投资基金管理办法》（温科发〔2025〕9号） （下称《市科创基金管理办法》）要求，现发布温州市科技创新创业投资基金（下称市科创基金）2025年度拟参股子基金申报指南，具体事项通知 如下： 一、申请条件 发起设立、管理子基金的子基金管理机构应当符合以下条件： （一）管理资质：子基金管理机构实缴资本不低于 1000 万元人民币，且必须在中国证券投资基金业协会登记。子基金管理机构应认缴不低于子基金 总规模 1%的出资额，若子基金管理机构关联方在子基金中有出资的，可降低至 0.5%，但合计不低于1%。 （二）管理团队：配备稳定的管理团队，至少有 3 名具备 3年以上股权投资或股权投资基金管理工作经验的高级管理人员，管理团队主要成员无受过 行政主管机关或司法机关处罚的不良记录。 （三）投资能力：管理机构在中国证券投资基金业协会备案的创业投资基金规模及私募股权投资基金不低于 2 亿元（包括管理团队以骨 ...

Core Viewpoint - The Guangdong Provincial Yueke Mother Fund is seeking to select excellent sub-fund management institutions to collaborate with its 15 mother funds through a regular selection process [2] Group 1: Mother Fund Overview - The Yueke Mother Fund will focus on strategic emerging industries in Guangdong Province, including high-quality projects related to the industrial chain of key industries [3] - The mother funds have specific investment requirements, including a maximum investment ratio of 50% of the sub-fund's total scale [3] - The sub-funds are expected to be newly established funds, with a minimum capital requirement of 50 million yuan [3] Group 2: Investment Areas and Requirements - Investment areas include advanced manufacturing, green energy, biomedicine, new materials, and other key development industries [3] - Sub-funds must align with the investment scope and requirements of the mother funds, focusing on high-quality projects within the specified industries [3] - The core management team of the sub-fund should hold a certain percentage of the fund's shares [3] Group 3: Selection Criteria - The selection process will consider the past performance of the fund management institutions and their ability to meet the investment goals set by the mother funds [4] - The mother fund's investment in a single sub-fund is generally not to exceed 30% of the sub-fund's total commitment [4] - Each investment tranche will be disbursed only after all other investors have completed their contributions [4]

Financial Performance - The company achieved operating revenue of 3.026 billion yuan, an increase of 4.63% compared to the same period last year [1][2] - The net profit attributable to shareholders was 455.57 million yuan, reflecting a growth of 12.60% year-on-year [1][3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 436.03 million yuan, up by 10.33% from the previous year [1][3] - The total profit for the period was 521.31 million yuan, compared to 464.09 million yuan in the same period last year [3] Cash Flow and Assets - The net cash flow from operating activities was 102.88 million yuan, a significant improvement from a negative cash flow of 249.98 million yuan in the previous year [3] - The net assets attributable to shareholders at the end of the reporting period were 8.057 billion yuan, slightly up from 8.047 billion yuan at the end of the previous year [3] - Total assets amounted to 10.808 billion yuan, compared to 10.780 billion yuan at the end of the previous year [3] Investment Activities - The company announced a partnership to establish a private equity investment fund, with a total commitment of 50 million yuan, where the company will contribute 10 million yuan, accounting for 20% of the fund [4] - The fund will focus on investing in companies aligned with national strategic emerging industries and future industry development directions [4] - The partnership has been officially registered with the China Securities Investment Fund Industry Association [4] Business Overview - The company operates in the pharmaceutical manufacturing sector, focusing on human medicine, animal health products, plant health, and food-drug homology [3] - It serves a global market, distributing products to 117 countries and regions across six continents, with over 5,000 supply partners including major pharmaceutical companies like Bayer, Eli Lilly, Abbott, and Novartis [3]

Group 1 - The article discusses the role of brokerage firms in supporting the real economy through alternative investment subsidiaries, highlighting the importance of optimizing resource allocation and enhancing service capabilities for technological innovation [1][2] - Northeast Securities announced a reduction in the registered capital of its wholly-owned subsidiary, Dongzheng Rongda Investment Co., Ltd., from 30 billion yuan to 10 billion yuan, reflecting a strategic decision to optimize business structure [2][3] - The reduction in registered capital is part of a broader trend among several brokerages, with Guodu Securities also announcing a capital reduction for its alternative investment subsidiary to improve overall capital efficiency [2][3] Group 2 - Alternative investment subsidiaries are crucial for brokerages, engaging in direct equity investments and participating in projects on the Sci-Tech Innovation Board and the Growth Enterprise Market, thereby contributing to the real economy and national strategies [2][3] - Some brokerages are increasing their investments in alternative investment businesses, such as Nanjing Securities planning to raise up to 1 billion yuan for investments in alternative and private equity subsidiaries [3] - Zhongtai Securities also plans to utilize funds raised from a private placement to increase capital for its alternative investment subsidiary, aiming to enhance project implementation and improve direct financing efficiency for the real economy [3]

Core Viewpoint - *ST Huamei's controlling shareholder will change to Jilin Provincial State-owned Assets Supervision and Administration Commission, and the stock will resume trading on June 26, 2025 [2][3][4] Group 1: Shareholder Change - Shanghai Pengsheng Technology Industry Co., Ltd. plans to transfer all its shares in *ST Huamei, totaling 214 million shares (22.32% of total share capital), to Jilin Yadong State-owned Capital Investment Co., Ltd. [7][8] - The transfer proceeds will primarily be used to repay the occupied funds and interest amounting to 1.556 billion yuan [7][9] Group 2: Financial and Regulatory Issues - *ST Huamei has faced internal control issues due to fund occupation and false disclosures, resulting in a fine of 10 million yuan from the Jilin Regulatory Bureau of the China Securities Regulatory Commission [12] - If *ST Huamei fails to recover 1.491 billion yuan of occupied funds by August 12, 2025, the Shanghai Stock Exchange will impose trading suspension and potential delisting warnings [12][13] Group 3: Company Overview - *ST Huamei is a national high-tech enterprise engaged in the design, research and development of power semiconductor devices, chip processing, packaging testing, and product marketing [13] - The company has a product range that includes IPM and PM modules, wide bandgap semiconductors, IGBT, MOS, FRD, SBD, SCR, and BJT, widely used in strategic emerging fields such as clean energy and automotive electronics [13] Group 4: Market Performance - As of June 18, *ST Huamei's stock price was 7.86 yuan per share, with a total market capitalization of 7.5 billion yuan [14]

Group 1 - The company has invested over 346 billion yuan in strategic emerging industries as of the end of April [1] - The investment has focused on leading enterprises in sectors such as semiconductors, storage chips, new energy batteries, and biotechnology [1]

Group 1 - The company, Daili New Materials (300700), announced a joint investment with Tainuo Capital and other professional institutions to establish the Shenzhen Tainuo Collaborative Innovation Seed Venture Capital Fund Partnership (Limited Partnership) [1] - The total committed capital of the fund is 163 million yuan, with the company contributing 10 million yuan, accounting for 6.12% of the total committed capital [1] - The fund primarily targets strategic emerging industries and future industries in Shenzhen, aiming to promote the development of emerging industries and maximize the interests of all partners [1]

Core Viewpoint - The Xiaoting Fund aims to promote industrial development and transformation in the Xiaoting District of Yichang City, focusing on strategic emerging industries through a combination of sub-funds and direct investments [1]. Group 1: Fund Structure and Investment Strategy - The Xiaoting Fund has a total paid-in capital of 203 million yuan, targeting investments in sectors such as new energy, modern chemicals, ecological protection, next-generation information technology, automotive components, and biomedicine [1]. - The fund will operate as a mother fund, collaborating with leading industry enterprises to establish sub-funds or directly invest in projects [1]. - At least 50% of the fund's total scale must be invested in sub-funds, with a maximum contribution of 30% to any single sub-fund, ensuring it does not become the largest or co-largest investor [1]. Group 2: Investment Focus - The fund will prioritize investments in key industries within the Xiaoting District, including new chemical materials, life sciences (synthetic biology), and high-end equipment manufacturing, targeting unicorns, hidden champions, and specialized innovative non-listed companies [1]. - Sub-funds established by the Xiaoting Fund are required to invest at least an amount equal to the fund's contribution in enterprises and major projects within the Xiaoting District [2].